JOE Society for Endocrinology Archive
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (1997) 154, 7-18       DOI: 10.1677/joe.0.1540007
© 1997 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (40)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phaneuf, S
Right arrow Articles by Bernal, A L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phaneuf, S
Right arrow Articles by Bernal, A L.

The desensitization of oxytocin receptors in human myometrial cells is accompanied by down-regulation of oxytocin receptor messenger RNA

S Phaneuf, G Asbóth, M P Carrasco, G N Europe-Finner, F Saji, T Kimura, A Harris and A López Bernal

We have recently provided evidence for the desensitization of oxytocin receptors in human myometrial cells. In the present study, we have investigated the possible mechanisms by which oxytocin (OT) might regulate OT receptor density. The steady state level of OT binding in cultured myometrial cells was 220 x 103 binding sites/cell, but this was time-dependently reduced to 27 x 103 sites/cell by exposure to OT for up to 20 h. Similarly, OT exposure decreased the binding of OT to cell membranes. In contrast, Western blotting data showed that the total amount of OT receptor protein was not affected by OT treatment for up to 48 h. Flow cytometry experiments demonstrated that OT receptors are not internalized during prolonged exposure of the cells to OT. However, RNase protection assays and Northern analysis showed that OT receptor mRNA was reduced by OT treatment to reach a new low steady state level with a time course similar to that of the disappearance of cell surface OT binding sites. Possible mechanisms involved in mRNA down-regulation include transcriptional suppression and destabilization of mRNA by RNA binding proteins.

Journal of Endocrinology (1997) 154, 7–18




This article has been cited by other articles:


Home page
Vet Rec.Home page
A. J. Barrett, R. D. Murray, R. M. Christley, H. Dobson, and R. F. Smith
Effects of the administration of oxytocin or carbetocin to dairy cows at parturition on their subsequent fertility
Vet Rec., November 21, 2009; 165(21): 623 - 626.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
A J Tyson-Capper, E A Shiells, and S C Robson
Interplay between polypyrimidine tract binding protein-associated splicing factor and human myometrial progesterone receptors
J. Mol. Endocrinol., July 1, 2009; 43(1): 29 - 41.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. K. R. S. Magalhaes, J. C. A. Carvalho, R. K. Parkes, J. Kingdom, Yong Li, and M. Balki
Oxytocin Pretreatment Decreases Oxytocin-induced Myometrial Contractions in Pregnant Rats in a Concentration-dependent But Not Time-dependent Manner
Reproductive Sciences, May 1, 2009; 16(5): 501 - 508.
[Abstract] [PDF]


Home page
EndocrinologyHome page
P. Ciarmela, E. Wiater, and W. Vale
Activin-A in Myometrium: Characterization of the Actions on Myometrial Cells
Endocrinology, May 1, 2008; 149(5): 2506 - 2516.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Ball, J. W. Wang, S. Wong, B. Zielnik, J. Mitchell, N. Wang, M. B. Stemerman, and B. F. Mitchell
Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E922 - E928.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. P. Smith, V. J. Ayad, S. J. Mundell, C. A. McArdle, E. Kelly, and A. Lopez Bernal
Internalization and Desensitization of the Oxytocin Receptor Is Inhibited by Dynamin and Clathrin Mutants in Human Embryonic Kidney 293 Cells
Mol. Endocrinol., February 1, 2006; 20(2): 379 - 388.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
O.N. Richter, C. Bartz, J. Dowaji, M. Kupka, J. Reinsberg, U. Ulrich, and W. Rath
Contractile reactivity of human myometrium in isolated non-pregnant uteri
Hum. Reprod., January 1, 2006; 21(1): 36 - 45.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Hasbi, D. Devost, S. A. Laporte, and H. H. Zingg
Real-Time Detection of Interactions between the Human Oxytocin Receptor and G Protein-Coupled Receptor Kinase-2
Mol. Endocrinol., May 1, 2004; 18(5): 1277 - 1286.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
O.N. Richter, K. Kubler, J. Schmolling, M. Kupka, J. Reinsberg, U. Ulrich, H. van derVen, E. Wardelmann, and K. van derVen
Oxytocin receptor gene expression of estrogen-stimulated human myometrium in extracorporeally perfused non-pregnant uteri
Mol. Hum. Reprod., May 1, 2004; 10(5): 339 - 346.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. P. H. Burbach, S. M. Luckman, D. Murphy, and H. Gainer
Gene Regulation in the Magnocellular Hypothalamo-Neurohypophysial System
Physiol Rev, July 1, 2001; 81(3): 1197 - 1267.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Schmid, S. Wong, and B. F. Mitchell
Transcriptional Regulation of Oxytocin Receptor by Interleukin-1{beta} and Interleukin-6
Endocrinology, April 1, 2001; 142(4): 1380 - 1385.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
G. Gimpl and F. Fahrenholz
The Oxytocin Receptor System: Structure, Function, and Regulation
Physiol Rev, April 1, 2001; 81(2): 629 - 683.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Imamura, C. E. Luedke, S. K. Vogt, and L. J. Muglia
Oxytocin modulates the onset of murine parturition by competing ovarian and uterine effects
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2000; 279(3): R1061 - R1067.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P. N. Rauk and J.-P. Chiao
Oxytocin Signaling in Human Myometrium Is Impaired by Prolonged Exposure to Interleukin-1
Biol Reprod, September 1, 2000; 63(3): 846 - 850.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. J. Pollard, C. Sparey, S. C. Robson, A. R. Krainer, and G. N. Europe-Finner
Spatio-Temporal Expression of the Trans-Acting Splicing Factors SF2/ASF and Heterogeneous Ribonuclear Proteins A1/A1B in the Myometrium of the Pregnant Human Uterus: A Molecular Mechanism for Regulating Regional Protein Isoform Expression in Vivo
J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1928 - 1936.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
T. Engstrom, P. Bratholm, H. Vilhardt, and N. J. Christensen
Effect of Oxytocin Receptor and ß2-Adrenoceptor Blockade on Myometrial Oxytocin Receptors in Parturient Rats
Biol Reprod, February 1, 1999; 60(2): 322 - 329.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Hatthachote, J. Morgan, W. Dunlop, G. N. Europe-Finner, and J. I. Gillespie
Gestational Changes in the Levels of Transforming Growth Factor-{beta}1 (TGF{beta}1) and TGF{beta} Receptor Types I and II in the Human Myometrium
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2987 - 2992.
[Abstract] [Full Text]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Society for Endocrinology.